Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cardona

Showing results (281-290 of 333) with videos related to

Pageof 34
Sort By:
Frontiers in Oncology|December 19, 2025
Correction: Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancerOscar Arrieta, Laura Margarita Bolaño-Guerra, Enrique Caballé-Pérez, et al.
Cancer Discovery|December 3, 2020
Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American PopulationsJian Carrot-Zhang, Giovanny Soca-Chafre, Nick Patterson, et al.
Lancet Regional Health. Americas|July 21, 2025
Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data studyAndrés F Cardona, Natalia Sánchez, Liliana Gutiérrez-Babativa, et al.
Lung Cancer (Amsterdam, Netherlands)|June 30, 2024
Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG studyOscar Arrieta, Enrique Caballé-Pérez, Norma Hernández-Pedro, et al.
Frontiers in Oncology|November 2, 2023
Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancerOscar Arrieta, Laura Margarita Bolaño-Guerra, Enrique Caballé-Pérez, et al.
Thoracic Cancer|July 25, 2020
Antibiotics impair immune checkpoint inhibitor effectiveness in Hispanic patients with non-small cell lung cancer (AB-CLICaP)Alejandro Ruiz-Patiño, Feliciano Barrón, Andrés F Cardona, et al.
Frontiers in Oncology|May 7, 2019
Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP)Andrés F Cardona, Leonardo Rojas, Zyanya Lucia Zatarain-Barrón, et al.
Targeted Oncology|October 5, 2018
EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP)Alejandro Ruiz-Patiño, Christian David Castro, Luisa María Ricaurte, et al.
The Lancet. Infectious Diseases|November 28, 2024
Safety and immunogenicity of mRNA-1345 RSV vaccine coadministered with an influenza or COVID-19 vaccine in adults aged 50 years or older: an observer-blinded, placebo-controlled, randomised, phase 3 trialJaya Goswami, Jose F Cardona, Denise C Hsu, et al.
JCO Global Oncology|January 18, 2024
Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid TumorsCarolina Sotelo-Rodríguez, Dora Vallejo-Ardila, Alejandro Ruiz-Patiño, et al.
Pageof 34

Showing results (281-290 of 333) with videos related to

Sort By:
Pageof 34
Frontiers in Oncology|December 19, 2025
Correction: Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancerOscar Arrieta, Laura Margarita Bolaño-Guerra, Enrique Caballé-Pérez, et al.
Cancer Discovery|December 3, 2020
Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American PopulationsJian Carrot-Zhang, Giovanny Soca-Chafre, Nick Patterson, et al.
Lancet Regional Health. Americas|July 21, 2025
Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data studyAndrés F Cardona, Natalia Sánchez, Liliana Gutiérrez-Babativa, et al.
Lung Cancer (Amsterdam, Netherlands)|June 30, 2024
Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG studyOscar Arrieta, Enrique Caballé-Pérez, Norma Hernández-Pedro, et al.
Frontiers in Oncology|November 2, 2023
Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancerOscar Arrieta, Laura Margarita Bolaño-Guerra, Enrique Caballé-Pérez, et al.
Thoracic Cancer|July 25, 2020
Antibiotics impair immune checkpoint inhibitor effectiveness in Hispanic patients with non-small cell lung cancer (AB-CLICaP)Alejandro Ruiz-Patiño, Feliciano Barrón, Andrés F Cardona, et al.
Frontiers in Oncology|May 7, 2019
Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP)Andrés F Cardona, Leonardo Rojas, Zyanya Lucia Zatarain-Barrón, et al.
Targeted Oncology|October 5, 2018
EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP)Alejandro Ruiz-Patiño, Christian David Castro, Luisa María Ricaurte, et al.
The Lancet. Infectious Diseases|November 28, 2024
Safety and immunogenicity of mRNA-1345 RSV vaccine coadministered with an influenza or COVID-19 vaccine in adults aged 50 years or older: an observer-blinded, placebo-controlled, randomised, phase 3 trialJaya Goswami, Jose F Cardona, Denise C Hsu, et al.
JCO Global Oncology|January 18, 2024
Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid TumorsCarolina Sotelo-Rodríguez, Dora Vallejo-Ardila, Alejandro Ruiz-Patiño, et al.
Pageof 34